文献速递创伤与烧伤复苏、休克与脓毒症儿科与产科急症

全血与成分输血在儿童创伤复苏中的全国性分析

A national analysis of whole blood versus component therapy in pediatric trauma resuscitations.
PubMed 文献 · Am J Emerg Med · 2025-06-03
一句话结论儿童创伤患者接受全血比例越高,24小时死亡 odds 越低,且所需总血制品量显著减少。

该研究基于美国外科医师学会创伤质量改进项目2020至2023年数据,纳入9091例接受全血或成分输血的儿童创伤患者,比较4小时、24小时及院内死亡,以及ICU住院时长、无呼吸机天数、并发症和全血占总输血量比例对结局的影响。结果显示全血比例越高,24小时死亡 odds 越低(OR 0.035,p=0.016);穿透伤中全血降低4小时(OR 0.176,p=0.033)和24小时(OR 0.337,p=0.025)死亡 odds;全血组所需总血制品量显著少于成分输血组。作者认为需未来研究进一步评估全血在特定损伤儿童中的潜在获益。

要点

  • 儿童创伤患者全血占总输血量比例越高,24小时死亡 odds 越低(OR 0.035,p=0.016)。
  • 穿透伤患儿接受全血者4小时死亡 odds 降低82%(OR 0.176,p=0.033),24小时降低66%(OR 0.337,p=0.025)。
  • 接受全血比例越高的患儿所需总血制品量显著少于接受成分输血者。
  • 4小时死亡(OR 0.077,p=0.156)和院内死亡(OR 0.531,p=0.124)的 odds 降低未达统计学显著。
  • 钝性或穿透伤儿童接受全血比例增加与24小时死亡 odds 降低相关,作者认为需未来研究进一步评估特定损伤中的潜在获益。

适用人群与场景

  • 2020至2023年美国外科医师学会创伤质量改进项目参与使用文件中接受全血或成分输血的儿童创伤患者,共9091例。

研究设计与关键结果

  • 研究类型为基于美国外科医师学会创伤质量改进项目参与使用文件(ACS-TQIP-PUF)2020至2023年的分析,纳入9091例接受全血或成分输血的儿童创伤患者。
  • 主要结局为4小时和24小时死亡;次要结局包括ICU住院时长、无呼吸机天数、并发症发生率及全血占总输血量比例对所需总输血量等结局的影响。
  • 全血比例越高,24小时死亡 odds 降低96%(OR 0.035,p=0.016);4小时死亡 odds 降低92%(OR 0.077,p=0.156),院内死亡 odds 降低47%(OR 0.531,p=0.124),均未达统计学显著。
  • 穿透伤中,全血降低4小时死亡 odds 82%(OR 0.176,p=0.033)、24小时死亡 odds 66%(OR 0.337,p=0.025)、院内死亡 odds 7%(OR 0.925,p=0.819),全血比例越高降低幅度越大。
  • 接受全血比例越高的患儿所需总血制品量显著少于接受成分输血者。

证据类型、等级与局限

  • 证据类型为基于美国外科医师学会创伤质量改进项目参与使用文件(ACS-TQIP-PUF)2020至2023年的分析。
  • 局限:作者指出需未来研究进一步评估全血在特定损伤儿童中的潜在获益,以提供更多支持其获益的证据。

对床旁实践的改变

  • 作者认为需未来研究进一步评估全血在特定损伤儿童中的潜在获益,以提供更多支持其获益的证据。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The aim of this study is to evaluate clinical outcomes among pediatric patients receiving whole blood (WB) transfusion, in addition to evaluating the ratio of WB to total transfused volume (TTV) based on trauma type.

METHODS: Pediatric trauma patients who received WB or component therapy (CT) were identified from the American College of Surgeons Trauma Quality Improvement Program Participant Use File (ACS-TQIP-PUF) from 2020 to 2023. The primary outcomes measured were mortality at 4-h and 24-h. Secondary outcomes included intensive care unit length of stay (ICU-LOS), ventilator-free days (VFD), complication rates and if the proportion of whole blood (WB) transfused relative to total transfusion volume (WB/TTV ratio) has any impact on outcomes such as amount of total transfusion volume required.

RESULTS: A total of 9091 pediatric trauma patients were included. A higher whole blood ratio reduced odds of 4-h (92 %, OR 0.077, p = 0.156), 24-h (96 %, OR 0.035, p = 0.016), and in-hospital (47 %, OR 0.531, p = 0.124) mortality. In penetrating trauma, whole blood reduced odds of 4-h (82 %, OR 0.176, p = 0.033), 24-h (66 %, OR 0.337, p = 0.025), and in-hospital (7 %, OR 0.925, p = 0.819) mortality, with further reductions at higher whole blood ratios.

CONCLUSION: Pediatric patients with blunt or penetrating injuries receiving an increasing amount of whole blood had reduced odds of 24-h mortality and required significantly less total blood products compared to patients receiving component therapy. Future research is required to further evaluate the potential benefits of whole blood in pediatric patients with specific injuries to provide additional evidence supporting its benefits.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kumar S, Nasef H, Chin B, et al. A national analysis of whole blood versus component therapy in pediatric trauma resuscitations. Am J Emerg Med. 2025. PMID: 40483871. doi:10.1016/j.ajem.2025.06.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。